Researcher Profiles
Related Websites
Alan R. Kristal
DegreesDr.P.H., Columbia University, Epidemiology, 1983. M.P.H., Northwestern University, Community Medicine, 1979. M.S., Framingham State College, Nutrition, 1976. Research InterestsMy primary research interests are in nutritional epidemiology, including the etiologic relationships between diet and cancer and implementation and evaluation of public health nutrition interventions. Current projects include studies on: (1) diet, dietary supplements and prostate cancer risk; (2) diet and neoplastic progression of Barrett's esophagus; (3) low-fat diet and breast cancer survival; and (4) dietary supplement use and cancer risk. MembershipsAmerican Association for Cancer Research American Society for Clinical Nutrition American Society for Nutritional Sciences American Society of Preventive Oncology Society for Epidemiologic Research |
Recent Publications
.
2013. Carbon and Nitrogen Stable Isotope Ratios Predict Intake of Sweeteners in a Yup'ik Study Population.. The Journal of nutrition. 143(2):161-5. Abstract
.
2012. Associations of Serum Sex Steroid Hormone and 5α-Androstane-3α,17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
.
2012. Reliability of Serum Biomarkers of Inflammation from Repeated Measures in Healthy Individuals.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
.
2012. Finasteride Reduces the Risk of Incident Clinical Benign Prostatic Hyperplasia.. European urology. Abstract
.
2012. Genetic Variation in GPX1 Is Associated with GPX1 Activity in a Comprehensive Analysis of Genetic Variations in Selenoenzyme Genes and Their Activity and Oxidative Stress in Humans.. The Journal of nutrition. 142(3):419-26. Abstract
.
2012. Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort.. Cancer causes & control : CCC. 23(3):431-444. Abstract
.
2012. Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 176(2):156-63. Abstract
.
2012. Stable nitrogen and carbon isotope ratios indicate traditional and market food intake in an indigenous circumpolar population.. The Journal of nutrition. 142(1):84-90. Abstract
.
2012. The Prevalence of Stunting Is High in HIV-1-Exposed Uninfected Infants in Kenya.. The Journal of nutrition. 142(4):757-63. Abstract
.
2011. Genetic Variation in Myeloperoxidase Modifies the Association of Serum {alpha}-Tocopherol with Aggressive Prostate Cancer among Current Smokers.. The Journal of nutrition. 141(9):1731-7. Abstract
.
2011. Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort.. Nutrition and cancer. 63(4):573-82. Abstract
.
2011. Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.. American journal of epidemiology. 173(12):1419-28. Abstract
.
2011. Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.. American journal of epidemiology. 173(12):1429-39. Abstract
.
2011. Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids.. European journal of clinical nutrition. 65(7):808-17. Abstract
.
2011. Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Carcinogenesis. 32(10):1500-1506. Abstract
.
2011. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.. Cancer causes & control : CCC. 22(8):1121-31. Abstract
.
2011. Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(4):638-46. Abstract
.
2011. Serum Selenium, Genetic Variation in Selenoenzymes, and Risk of Colorectal Cancer: Primary Analysis from the Women's Health Initiative Observational Study and Meta-analysis.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(9):1822-30. Abstract
.
2010. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.. American journal of epidemiology. 172(5):566-77. Abstract
.
2010. Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(22):5414-23. Abstract
.
2010. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 171(5):571-82. Abstract
.
2010. Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos.. The American journal of clinical nutrition. 91(3):777-85. Abstract
.
2010. Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Cancer prevention research (Philadelphia, Pa.). 3(3):279-89. Abstract
